Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 5, Number 3—June 1999
Perspective

Use of Antimicrobial Growth Promoters in Food Animals and Enterococcus faecium Resistance to Therapeutic Antimicrobial Drugs in Europe

Henrik C. WegenerComments to Author , Frank M. Aarestrup, Lars Bogø Jensen, Anette M. Hammerum, and Flemming Bager
Author affiliations: Danish Veterinary Laboratory, Copenhagen, Denmark

Main Article

Figure

Trend in the proportion of Enterococcus faecium isolates resistant to vancomycin (VRE) during successive half-year periods from second half of 1995 to first half of 1998 (39).

Figure. Trend in the proportion of Enterococcus faecium isolates resistant to vancomycin (VRE) during successive half-year periods from second half of 1995 to first half of 1998 (39).

Main Article

References
  1. Edmond  MB, Ober  JF, Weinbaum  DL, Pfaller  MA, Hwang  T, Sanford  MD, Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995;20:1126–33.PubMed
  2. Leclerq  R, Derlot  E, Duval  J, Courvalin  P. Plasmid mediated resistance to vancomycin and teicoplanin in Enterococccus faecium. N Engl J Med. 1988;319:157–61.PubMed
  3. Centers for Disease Control and Prevention. Summary of Notifiable Diseases—United States, 1997. MMWR Morb Mortal Wkly Rep. 1998;46:1–87.
  4. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep. 1995;44:RR12.
  5. House of Lords Select Committee on Science and Technology. Resistance to antibiotics and other antimicrobial agents. 1998. London: The Stationary Office; 1998.
  6. Bates  J, Jordens  J, Griffith  DT. Farm animals as a putative reservoir for vancomycin resistant enterococcal infections in man. J Antimicrob Chemother. 1994;34:507–16. DOIPubMed
  7. Klare  I, Heier  H, Claus  H, Reissbrodt  R, Van Witte  W. A-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett. 1995;125:165–72. DOIPubMed
  8. Jensen  BB. The impact of feed additives on the microbial ecology of young pigs. J Anim Feed Sci. 1998;7:45–64.
  9. McDonald  CL, Kuehnert  MJ, Tenover  FC, Jarvis  WR. Vancomycin-resistant enterococci outside the health care setting: prevalence, sources, and public health. Emerg Infect Dis. 1997;3:311–7. DOIPubMed
  10. Wegener  HC. Historical usage of glycopeptides for animals and humans—the American/European paradox revisited. Antimicrob Agents Chemother. 1998;42:3049.PubMed
  11. Witte  W. Medical consequences of antibiotic use in agriculture. Science. 1998;279:996–7. DOIPubMed
  12. Kirst  HA, Thompson  DG, Nicas  TI. Historical yearly usage of vancomycin [letter]. Antimicrob Agents Chemother. 1998;42:1303–4.PubMed
  13. Aarestrup  FM. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from ecological and conventional poultry farms. Microb Drug Resist. 1995;1:255–7. DOIPubMed
  14. Bager  F, Madsen  M, Christensen  J, Aarestrup  FM. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev Vet Med. 1997;31:95–112. DOIPubMed
  15. Devriese  LA, Ieven  M, Goosens  H, Vandamme  P, Pot  B, Hommez  J, Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob Agents Chemother. 1996;40:2285–7.PubMed
  16. Tast  E, Myllys  V, Honkanen-Buzalski  T. A survey of resistance to some antimicrobials of enterococcal and E. coli strains isolated from pigs and broilers in Finland. In: Proceedings of NKVet Symposium on Antibiotic Resistance. 1997 Nov 7-8. Danish Veterinary Association, Sundvolden, Norway. p. 44.
  17. Boisivon  A, Vauchel  JC, Cheron  M, Gobert  A, Leturdu  F, Chambreuil  G, Vancomycin resistant enterococci (VRE) from food animal sources in France. In: Proceedings of the 97th General Meeting of the American Society of Microbiology; 1997 May 4-8; Miami Beach, Florida. Washington: American Society of Microbiology; 1997.
  18. van den Bogaard  AE, Jensen  LB, Stobberingh  EE. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med. 1997a;337:1558–9. DOIPubMed
  19. Simonsen  GS, Haaheim  H, Kruse  H, Dahl  KH, Olsvik  Ø, Sundsfjord  A. Glycopeptide resistant Enterococci (GRE) at avoparcin-using farms: possible transmission of strains and the vanA gene cluster between chicken and humans. In: Proceedings of NKVet Symposium on Antibiotic Resistance. 1997 Nov 7-8. Danish Veterinary Association, Sundvolden, Norway. p. 41.
  20. Quednau  M, Ahrné  S, Molin  G. Antibiotic resistant enterococci in Swedish and Danish pork and poultry. In: Proceedings of Symposium on Food Associated Pathogens; 1996 May 6-8; The Swedish University of Agricultural Sciences, The Swedish National Committee of Food Science and Technology, and the International Union of Food Science and Technology, Uppsala, Sweden. p. 254.
  21. Coque  TM, Tomayko  JF, Ricke  SC, Okhuysen  PC, Murray  B. Vancomycin-resistant enterococci from nosocomial, community and animal sources in the United States. Antimicrob Agents Chemother. 1996;40:2605–9.PubMed
  22. Thal  LA, Chow  JW, Mahayni  R, Bonilla  H, Donabedian  SA, Silverman  J, Characterization of antimicrobial resistance in enterococci of animal origin. Antimicrob Agents Chemother. 1996;39:2112–5.
  23. Wegener  HC, Madsen  M, Nielsen  N, Aarestrup  FM. Isolation of vancomycin resistant Enterococcus faecium from food. Int J Food Microbiol. 1997;35:57–66. DOIPubMed
  24. Danish Zoonosis Centre. Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. No. 1, Feb 1997. Copenhagen, Denmark: Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP).
  25. Silverman  J, Thal  LA, Perri  MB, Bostic  G, Zervos  MJ. Epidemiological evaluation of antimicrobial resistance in community-acquired enterococci. J Clin Microbiol. 1998;36:830–2.PubMed
  26. Van der Auwera  P, Pensart  N, Korten  V, Murray  B. Influence of oral glycopeptides on the faecal flora of human volunteers: selection of highly glycopeptide resistant enterococci. J Infect Dis. 1996;173:1129–36.PubMed
  27. Gordts  B, Van Landuyt  H, Ieven  M, Vandamme  P, Goossens  H. Vancomycin-resistant enterococci colonizing the intestinal tract of hospitalized patients. J Clin Microbiol. 1995;33:2842–6.PubMed
  28. Schouten  MA, Voss  A, Hoogkamp-Korstanje  JAA. VRE and meat. Lancet. 1997;349:1258. DOIPubMed
  29. Ieven  M, Vercauteren  E, Descheemaeker  P, Goosens  H. Significant increase in detection of intestinal carriers of glycopeptide resistant enterococci by enrichment cultures [abstract] In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 30, 1997; Toronto, Canada. Abstract D-118.
  30. Van den Brak  N, van Belkum  A, van Keulen  M, Vliegendhart  J, Verbrugh  HA, Endtz  HP. Molecular characterisation of vancomycin-resistant enterococci from hospitalised patients and poultry products in the Netherlands. J Clin Microbiol. 1998;36:1927–32.PubMed
  31. Arthur  M, Courvalin  P. Genetics and mechanisms of glycopetide resistance in enterococci. Antimicrob Agents Chemother. 1993;37:95–112.
  32. Aarestrup  FM, Ahrens  P, Madsen  M, Pallesen  LV, Poulsen  RL, Westh  H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother. 1996;40:1938–40.PubMed
  33. Leclercq  R, Derlot  E, Weber  M, Duval  J, Courvalin  P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1989;33:10–5.PubMed
  34. Noble  WC, Virani  Z, Cree  RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992;72:195–8. DOIPubMed
  35. Berchieri  A. Intestinal colonization of a human subject by vancomycin-resistant Enterococcus faecium. Clin Microbiol Infect. 1999;5:97–100. DOIPubMed
  36. Jensen  LB, Ahrens  P, Dons  L, Jones  RN, Hammerum  A, Aarestrup  FM. Molecular analysis of the Tn1546 from vancomycin resistant enterococci isolated from animals and humans. J Clin Microbiol. 1998;36:437–42.PubMed
  37. Jensen  LB. Differences in the occurrence of two base pair variants of Tn1546 from vancomycin-resistant enterococci from humans, pigs and poultry. Antimicrob Agents Chemother. 1998;42:2463–4.PubMed
  38. Thal  L, Donabedian  S, Robinson-Dunn  B, Chow  JW, Dembry  L, Clewell  DB, Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period. J Clin Microbiol. 1998;36:3303–8.PubMed
  39. Bager  F, Aarestrup  FM, Madsen  M, Wegener  HC. Glycopeptide resistance in Enterococcus faecium from broilers following discontinued use of avoparcin. Microb Drug Resist. 1999;5. In press. DOIPubMed
  40. Klare  I, Badstübner  D, Konstabel  C, Böhme  G, Claus  H, Witte  W. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist. 1999;5. In press. DOIPubMed
  41. Welton  LA, Thal  LA, Perri  MB, Donabedien  S, McMahon  J, Chow  JW, Antimicrobial resistance in enterococci isolated from turkey flocks fed virginiamycin. Antimicrob Agents Chemother. 1998;42:705–8.PubMed
  42. Van den Bogaard  AE, Mertens  P, London  NH, Stobberingh  EE. High prevalence of vancomycin- and pristinamycin-resistant enterococci in healthy humans and animals in The Netherlands: is the addition of antibiotics to animal feed to blame? Antimicrob Agents Chemother. 1997;40:454–6. DOI
  43. Aarestrup  FM, Bager  F, Madsen  M, Jensen  NE, Meyling  A, Wegener  HC. Surveillance of antimicrobial resistance in bacteria isolated from food animals to growth promoters and related therapeutic agents in Denmark. APMIS. 1998;106:606–22. DOIPubMed
  44. Hammerum  AH, Jensen  LB, Aarestrup  FM. Detection of the SatA gene and transferability of virginiamycin resistance in Enterococcus faecium from food animals. FEMS Microbiol Lett. 1998;168:145–51. DOIPubMed
  45. Jakobsen  BM, Skou  M, Hammerum  AM, Jensen  LB. In vivo transfer of the satA gene between isogenic strains of Enterococcus faecium in the mammalian gastrointestinal tract. In: Proceedings of the Second World Congress on Anaerobic Bacteria and Infections; 1998 Oct 3-6; Nice, France.
  46. Aarestrup  FM. Association between decreased susceptibility to a new antibiotic for treatment of human diseases; everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin. Microb Drug Resist. 1998;4:137–41. DOIPubMed
  47. The medical impact of the use of antimicrobials in food animals. Report from a WHO meeting; Berlin, Germany 1997 Oct 13-17. Geneva: World Health Organization; 1997.
  48. The role of international trade in animals, animal products and feed in the spread of transferable antimicrobial resistance and possible methods for control of the spread of infectious agent resistance factors. In: Proceedings of the 18th Conference of the Office International des Epizooties (OIE) Regional Commission of Europe; 1998 Sep 22-25; Prague, Czech Republic.
  49. The Copenhagen recommendation. Report from the invitational EU conference on the microbial threat; 1998 Sep 9-10; Copenhagen, Denmark. (Internet address http://www.sum.dk/publika/micro98/index.htm).
  50. Commission regulation of amending council directive 70/524/EEC concerning additives in feedingstuffs as regards withdrawal of the authorisation of certain antibiotics. Document No.: VI/7767/98. European Commission, Brussels, Belgium.

Main Article

Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external